Pituitary adenoma…nomen omen?

被引:0
作者
Andrea Giustina
机构
[1] Vita-Salute University and IRCCS Hospital,Institute of Endocrine and Metabolic Sciences, San Raffaele
来源
Endocrine | 2021年 / 74卷
关键词
Pituitary adenoma; Neuroendocrine tumor; Pituitary pathology; Acromegaly; Prolactinoma; Cushing disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 4
页数:3
相关论文
共 430 条
[1]  
Lopes MBS(2017)The 2017 World Health Organization classification of tumors of the pituitary gland: a summary Acta Neuropathol. 134 521-535
[2]  
Asa SL(2017)From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal Endocr. Relat. Cancer 24 C5-C8
[3]  
Casar-Borota O(2019)A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement Pituitary 22 569-573
[4]  
Chanson P(2020)Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution Pituitary 23 322-325
[5]  
Delgrange E(2020)The tale in evolution: clarity, 21 consistency and consultation, not contradiction and confusion Pituitary 23 476-477
[6]  
Earls P(2021)Pituitary Neoplasm Nomenclature Workshop: does adenoma stand the test of time? J. Endocr. Soc. 5 bvaa205-678
[7]  
Ezzat S(2020)Multidisciplinary management of acromegaly: a consensus Rev. Endocr. Metab. Disord. 21 667-536
[8]  
Grossman A(2020)A consensus on the diagnosis and treatment of acromegaly comorbidities: an update J. Clin. Endocrinol. Metab. 105 dgz096-99, viii
[9]  
Ikeda H(2020)The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): a surgical perspective Rev. Endocr. Metab. Disord. 21 527-564
[10]  
Inoshita N(2008)Hyperprolactinemia and prolactinomas Endocrinol. Metab. Clin. North Am. 37 67-950